Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Gallo-Oller

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Plos One|November 14, 2014
Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cellsRaquel Ordóñez, Gabriel Gallo-Oller, Soledad Martínez-Soto, et al.
Cancers|November 13, 2021
High Expression of <i>PPM1D</i> Induces Tumors Phenotypically Similar to <i>TP53</i> Loss-of-Function Mutations in MiceJelena Milosevic, Susanne Fransson, Miklos Gulyas, et al.
Cancers|March 29, 2023
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the AmpliconGuillem Pons, Gabriel Gallo-Oller, Natalia Navarro, et al.
Cancers|February 11, 2023
Targeting the Hedgehog Pathway in RhabdomyosarcomaPatricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, et al.
International Journal of Molecular Sciences|December 10, 2021
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In VivoIrina Giralt, Gabriel Gallo-Oller, Natalia Navarro, et al.
Scientific Reports|April 19, 2017
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluationEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Experimental Hematology & Oncology|April 5, 2024
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcomaGabriel Gallo-Oller, Guillem Pons, Júlia Sansa-Girona, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos One|November 14, 2014
Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cellsRaquel Ordóñez, Gabriel Gallo-Oller, Soledad Martínez-Soto, et al.
Cancers|November 13, 2021
High Expression of <i>PPM1D</i> Induces Tumors Phenotypically Similar to <i>TP53</i> Loss-of-Function Mutations in MiceJelena Milosevic, Susanne Fransson, Miklos Gulyas, et al.
Cancers|March 29, 2023
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the AmpliconGuillem Pons, Gabriel Gallo-Oller, Natalia Navarro, et al.
Cancers|February 11, 2023
Targeting the Hedgehog Pathway in RhabdomyosarcomaPatricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, et al.
International Journal of Molecular Sciences|December 10, 2021
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In VivoIrina Giralt, Gabriel Gallo-Oller, Natalia Navarro, et al.
Scientific Reports|April 19, 2017
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluationEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Experimental Hematology & Oncology|April 5, 2024
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcomaGabriel Gallo-Oller, Guillem Pons, Júlia Sansa-Girona, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Pageof 2